Navigating the Data and Evolving Our Approach

Slides:



Advertisements
Similar presentations
Advancing Care Forward in Squamous Cell Carcinoma of the Head and Neck
Advertisements

Fostering a Collaborative Approach in the Management of BRCA-Mutated Ovarian Cancer.
Evolving Standards in HER2-Targeted Adjuvant Therapy for Breast Cancer
Bladder Cancer: A New Era in Treatment
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
State of the Art in BRCA-Mutated Ovarian Cancer
Immunotherapies: Key Considerations in the Identification and Management of irAEs.
Evolving Paradigms in the Management of HR-Positive Breast Cancer
New Psoriasis Treatments
Please note this program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.
Applying Biosimilars in Hematologic Cancers
T-Cell Exhaustion: Can We Overcome It in Cancer?
Advances in Managing Inhibitors in Patients With Hemophilia A
Progression After Cancer Immunotherapy in Advanced NSCLC
Standards of Care in Duchenne Muscular Dystrophy: A 2018 Update
Expert Perspectives on Best Practices for Diagnosis and Management of Spinal Muscular Atrophy.
New Standards of Care in ALK-Translocated Advanced NSCLC
Induction Chemotherapy for Patients With High-Risk or Secondary AML
Determining the Best Treatment Algorithm for Patients With Head and Neck Cancer.
Treating Transplant-Ineligible Patients With Multiple Myeloma
Assessing Newer Treatment Approaches for Multiply Relapsed Multiple Myeloma.
BTK Inhibitors in Relapsed/Refractory Mantle Cell Lymphoma
Aligning Patients and Clinicians: Optimizing Outcomes in Metastatic NSCLC.
Expanding Treatment Horizons in Head and Neck Cancer: TRK Inhibitors
Emerging Targeted Agents for Relapsed/Refractory Non-Hodgkin Lymphoma
The Nurse View.
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data.
Updates in Preventing Skeletal-Related Events in Multiple Myeloma
Individualizing Care in Ovarian Cancer
Addressing Challenges in Factor VIII Inhibitors in Children With Hemophilia.
Postpartum Depression
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Evaluating Next-Generation BTK Inhibitors
Case Studies in Unresectable Hepatocellular Carcinoma
Hyperhidrosis Is Burdensome!
Targeting BTK Signaling in B-Cell Malignancies
Essential Concepts in the Use of Immunotherapies in Bladder Cancer
The JAK-STAT Pathway and Graft-vs-Host Disease
Optimizing Frontline Care for Older Patients With Multiple Myeloma
How to Effectively Manage Patients With Cutaneous Squamous Cell Carcinoma.
Advancing Care Across the Spectrum of Pancreatic Cancer
Expert Perspectives on the Clinical Use of Immune Reconstitution vs Escalation Therapy for MS.
Parkinson Disease Psychosis
Talking With Your Patients About Excessive Sweating
Updates in the Management of Acute Promyelocytic Leukemia
Advances in Immunotherapy for Peanut Allergy
Locally Advanced Lung Cancer
Guide to Atopic Dermatitis
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Molecular Testing in Ovarian Cancer: Is the Time Now?
Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC
Patient Questions and Expert Answers in Psoriasis:
The Role of Maintenance Therapy in Multiple Myeloma
Evaluating BTK Inhibitors in CLL
All for One: Multidisciplinary Management in EGFR-Mutated NSCLC
The Psychiatrist's Role in Tardive Dyskinesia
Patient and Clinician Perspectives on Preventive Therapy for Migraine
Novel Concepts in the Management of RCC
From Adjuvant to Metastatic in Melanoma
Why New Treatments for Hyperhidrosis Should Be on Your Radar
The Nurse View: Spotlight on Immune Checkpoint Inhibitors in Advanced Lung Cancer.
Prioritizing Prevention of HPV-Related Disease
Case Studies in Locally Advanced Pancreatic Cancer
The Psychiatrist's Role in Tardive Dyskinesia
Checkpoint Inhibitors in First-Line Advanced NSCLC
VKA Reversal and LVADs.
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Moving Care Forward in Advanced Gastric Cancer
Next-Generation Sequencing and ctDNA
Immune Checkpoint Inhibitors in Lung Cancer
Presentation transcript:

Navigating the Data and Evolving Our Approach

This program will include a discussion of medical devices not approved by the FDA for use in the United States, and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.

High-Risk HPV Causes Cervical Cancer

Cervical Cancer Screening Development

Cervical Cancer in the United States

How HPV Can Lead to Cervical Cancer

Cervical Cancer Screening in the United States

HPV Screening

Lifetime Risk of Cervical Cancer

Cumulative Risk of Cervical Intraepithelial Neoplasia/Cervical Cancer by Test

FOCAL Study

FOCAL Study Co-testing Results

Guidelines

Management After a Positive Test

Patient Education Points for the Care Team

Future Directions

Key Takeaways

Abbreviations